English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on the arachidonic acid (AA)-induced responses were investigated in the isolated canine coronary artery superfused with blood from a donor dog and Krebs-Henseleit solution. When the coronary artery was superfused with Krebs-Henseleit solution, AA did not have any remarkable effect on its tone. In the coronary artery superfused with blood, in contrast, AA (10-100 micrograms) caused phasic constriction followed by relaxation. After denudation of the endothelium, the contractile response was augmented, and the relaxant effect was abolished. Y-20811 (1 mg/kg, i.v.), administered into the donor dog, inhibited the contraction and augmented the relaxation. Indomethacin (5 mg/kg, i.v.) and aspirin (30 mg/kg, i.v.) also inhibited the AA-induced contraction. However, indomethacin inhibited the relaxation induced by AA (10-100 micrograms), whereas aspirin inhibited the relaxation induced by a low dose of AA (10-30 micrograms). These results suggest that Y-20811 inhibits the TXA2-induced contraction and augments the production of the relaxant metabolite of AA in the coronary artery.

Effect of Y-20811, a thromboxane A2 synthetase inhibitor, on the arachidonic acid-induced response in the blood-superfused canine coronary artery.